Eligibility
and Disqualification Recommendations for Competitive Athletes With
Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific
Statement From the American Heart Association and American College of
Cardiology
and Disqualification Recommendations for Competitive Athletes With
Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific
Statement From the American Heart Association and American College of
Cardiology
Barry J. Maron, Kevin M. Harris, Paul D.
Thompson, E. Randy Eichner, Martin H. Steinberg, and on behalf of the American
Heart Association Electrocardiography and Arrhythmias Committee of the Council
on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council
on Cardiovascular and Stroke Nursing, Council on Functional Genomics and
Translational Biology, and the American College of Cardiology
Thompson, E. Randy Eichner, Martin H. Steinberg, and on behalf of the American
Heart Association Electrocardiography and Arrhythmias Committee of the Council
on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council
on Cardiovascular and Stroke Nursing, Council on Functional Genomics and
Translational Biology, and the American College of Cardiology
Circulation. 2015; published online
before print November 2 2015, doi:10.1161/CIR.0000000000000250
before print November 2 2015, doi:10.1161/CIR.0000000000000250
The American Heart Association and
American College of Cardiology have released a series of scientific statements
regarding eligibility and disqualification recommendation for competitive
athletes with cardiovascular abnormalities. This is the second to last document
of 15 scientific statements. This document discusses athletes with a sickle
cell trait. The document includes 4 recommendations at the end of the document.
American College of Cardiology have released a series of scientific statements
regarding eligibility and disqualification recommendation for competitive
athletes with cardiovascular abnormalities. This is the second to last document
of 15 scientific statements. This document discusses athletes with a sickle
cell trait. The document includes 4 recommendations at the end of the document.